Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig
- PMID: 2821181
- DOI: 10.1099/0022-1317-68-9-2449
Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig
Abstract
Strain 2 guinea-pigs were inoculated with infectious varicella-zoster virus (VZV) or with immunoaffinity-purified proteins of VZV. Monoclonal antibodies to the VZV gpI (90,000/58,000 complex) and to a non-glycosylated protein, p170, were used to prepare the polypeptide antigens. Humoral and cell-mediated immune responses to the infectious virus were compared with those elicited by the gpI and p170 proteins. Both VZV IgG antibody production and T lymphocyte proliferation to VZV were detected after immunization with infectious VZV and with VZV proteins. The antibody and T lymphocyte responses waned after protein immunization in comparison with the responses induced by infectious VZV but were detected again immediately after reimmunization with gpI or p170.
Similar articles
-
Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.J Gen Virol. 1992 Apr;73 ( Pt 4):811-9. doi: 10.1099/0022-1317-73-4-811. J Gen Virol. 1992. PMID: 1321876
-
Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.J Infect Dis. 1988 Dec;158(6):1245-52. doi: 10.1093/infdis/158.6.1245. J Infect Dis. 1988. PMID: 2848901
-
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.J Immunol. 1986 Aug 15;137(4):1346-51. J Immunol. 1986. PMID: 3016094
-
Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.Mol Biol Med. 1989 Oct;6(5):453-62. Mol Biol Med. 1989. PMID: 2560525 Review.
-
Animal models of varicella.J Infect Dis. 1992 Aug;166 Suppl 1:S48-50. doi: 10.1093/infdis/166.supplement_1.s48. J Infect Dis. 1992. PMID: 1320650 Review.
Cited by
-
Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.J Virol. 1991 Oct;65(10):5593-6. doi: 10.1128/JVI.65.10.5593-5596.1991. J Virol. 1991. PMID: 1654454 Free PMC article.
-
Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system.J Neurovirol. 2014 Oct;20(5):442-56. doi: 10.1007/s13365-014-0259-1. Epub 2014 Jun 26. J Neurovirol. 2014. PMID: 24965252 Free PMC article.
-
Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.J Virol. 1989 May;63(5):2392-5. doi: 10.1128/JVI.63.5.2392-2395.1989. J Virol. 1989. PMID: 2539528 Free PMC article.
-
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.J Virol. 1997 Nov;71(11):8279-88. doi: 10.1128/JVI.71.11.8279-8288.1997. J Virol. 1997. PMID: 9343180 Free PMC article.
-
T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.J Virol. 1990 Feb;64(2):651-5. doi: 10.1128/JVI.64.2.651-655.1990. J Virol. 1990. PMID: 2153231 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources